Pharmacokinetics of abuse deterrent, extended release once-a-day dosage forms of levorphanol: a single-dose, 5-way crossover study.
Phase of Trial: Phase I
Latest Information Update: 21 May 2012
At a glance
- Drugs Levorphanol (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 21 May 2012 New trial record
- 19 May 2012 Results presented at the 31st Annual Scientific Meeting of the American Pain Society.